My point exactly Latino. Agree also funding is desperate and i may come heavily discounted, however weighing up their new contracts/revenue and recent game changer breakthrough i have a feeling this will bounce hard from this price
I would have though a 'top ten pharma' would have done the necessary due diligence on the long term relationship and operability of a company before entering into a contract. The same i guess would apply to the other companies/contracts. I think personally that this is a strong hint that funding has been agreed. This company was over £80M mcap almost a year ago!!! It peaked at 28p on the breakthrough news only a few weeks ago. I see this 10p++ in the very short term . . .